Author(s)

Azar Tol, Bahram Mohebbi, Mostafa Hossaini, Fereshteh Majlessi

Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Department of Health Education and Promotion, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Hasheminejad Clinical Development Research center, Hasheminejad Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Introduction: This study aimed to develop valid and reliable scale with the intention of measure Coping Self-efficacy (CSES) of Iranian type 2 diabetic patients. Patients and Methods: Validity and reliability of Iranian version of Coping Self-efficacy Scale (CSES) were measured by a cross-sectional study. Content validity, reliability and cultural equivalency were appraised through qualitative and quantitative study on 260 participants who have type 2 diabetes. Results: Reliability and validity of the scale and its four subscales, such as “stop unpleasant emotions and thoughts” (a = 0.92) “used problem-focused coping” (a = 0.71), Self-efficacy on diabetes problem solving (a = 0.74) and “get support from friends and family” (a = 0.67) were approved explicitly by a psychometric analysis; these show that the scale was slightly valid and reliable on the study setting. An intraclass correlation coefficient was satisfactory (p < 0.001). Criterion validity between total scale and metabolic control Index (HbA1c) of type 2 diabetic patients was significant (p < 0.001) and showed indirect correlation with the domains of the scale. Conclusion: Study findings supported the reliability and validity of the Iranian version of new Coping Self-efficacy-24 for measuring Coping Selfefficacy among Iranian type 2 diabetic patients. Based on our finding, we would like to recommend appropriate interventions in the future.

Coping Self-Efficacy; Type 2 Diabetes; Reliability; Validity; Iranian Version

Tol, A. , Mohebbi, B. , Hossaini, M. and Majlessi, F. (2014) Developing a Valid and Reliable Coping Self-Efficacy Scale (CSES) among Patients with Type 2 Diabetes: Iranian Version. Open Journal of Endocrine and Metabolic Diseases, 4, 45-51. doi: 10.4236/ojemd.2014.43005.